These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15962118)

  • 1. Protease-activated receptors and inflammatory hyperalgesia.
    Vergnolle N
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():173-6. PubMed ID: 15962118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease signaling to G protein-coupled receptors: implications for inflammation and pain.
    Dale C; Vergnolle N
    J Recept Signal Transduct Res; 2008; 28(1-2):29-37. PubMed ID: 18437628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The enteric nervous system in inflammation and pain: the role of proteinase-activated receptors.
    Vergnolle N
    Can J Gastroenterol; 2003 Oct; 17(10):589-92. PubMed ID: 14571293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of spinal constitutive NOS-2 by 1400W attenuates tissue injury and inflammation-induced hyperalgesia and spinal p38 activation.
    Tang Q; Svensson CI; Fitzsimmons B; Webb M; Yaksh TL; Hua XY
    Eur J Neurosci; 2007 May; 25(10):2964-72. PubMed ID: 17561811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal roles for proteinase-activated receptors in health and disease.
    Kawabata A; Matsunami M; Sekiguchi F
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S230-40. PubMed ID: 17994114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway.
    Vergnolle N; Bunnett NW; Sharkey KA; Brussee V; Compton SJ; Grady EF; Cirino G; Gerard N; Basbaum AI; Andrade-Gordon P; Hollenberg MD; Wallace JL
    Nat Med; 2001 Jul; 7(7):821-6. PubMed ID: 11433347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal administration of proteinase-activated receptor-2 agonists produces hyperalgesia by exciting the cell bodies of primary sensory neurons.
    Alier KA; Endicott JA; Stemkowski PL; Cenac N; Cellars L; Chapman K; Andrade-Gordon P; Vergnolle N; Smith PA
    J Pharmacol Exp Ther; 2008 Jan; 324(1):224-33. PubMed ID: 17921188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protease-activated receptor-1 (PAR1) and PAR2 but not PAR4 mediate relaxations in lower esophageal sphincter.
    Huang SC
    Regul Pept; 2007 Jul; 142(1-2):37-43. PubMed ID: 17335921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallikreins and proteinase-mediated signaling: proteinase-activated receptors (PARs) and the pathophysiology of inflammatory diseases and cancer.
    Hollenberg MD; Oikonomopoulou K; Hansen KK; Saifeddine M; Ramachandran R; Diamandis EP
    Biol Chem; 2008 Jun; 389(6):643-51. PubMed ID: 18627296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of protease-activated receptor-2 in inflammation, and its possible implications as a putative mediator of periodontitis.
    Holzhausen M; Spolidorio LC; Vergnolle N
    Mem Inst Oswaldo Cruz; 2005 Mar; 100 Suppl 1():177-80. PubMed ID: 15962119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal protease-activated receptor stimulation produces thermal hyperalgesia through spinal cyclooxygenase activity.
    Koetzner L; Gregory JA; Yaksh TL
    J Pharmacol Exp Ther; 2004 Oct; 311(1):356-63. PubMed ID: 15175421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protease-activated receptors in the Achilles tendon-a potential explanation for the excessive pain signalling in tendinopathy.
    Christensen J; Alfredson H; Andersson G
    Mol Pain; 2015 Mar; 11():13. PubMed ID: 25880199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteinase-activated receptors (PARs) in infection and inflammation in the gut.
    Vergnolle N
    Int J Biochem Cell Biol; 2008; 40(6-7):1219-27. PubMed ID: 18313348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors: how proteases signal to cells to cause inflammation and pain.
    Bunnett NW
    Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():39-48. PubMed ID: 16673265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of protease-activated receptors 2 (PAR2) in ocular infections and inflammation.
    Tripathi T; Alizadeh H
    Receptors Clin Investig; 2014; 1(6):. PubMed ID: 26078987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteases and protease-activated receptors (PARs): novel signals for pain.
    Cenac N; Vergnolle N
    Curr Top Med Chem; 2005; 5(6):569-76. PubMed ID: 16022679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARs in the inflammation-cancer transformation of CRC.
    Lv J; Liu J; Chao G; Zhang S
    Clin Transl Oncol; 2023 May; 25(5):1242-1251. PubMed ID: 36547764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-terminus of murine S100A9 protein inhibits hyperalgesia induced by the agonist peptide of protease-activated receptor 2 (PAR2).
    Dale CS; Cenac N; Britto LR; Juliano MA; Juliano L; Vergnolle N; Giorgi R
    Br J Pharmacol; 2006 Oct; 149(4):374-84. PubMed ID: 16967049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology and pathophysiology of proteinase-activated receptors (PARs): proteinases as hormone-like signal messengers: PARs and more.
    Hollenberg MD
    J Pharmacol Sci; 2005 Jan; 97(1):8-13. PubMed ID: 15665444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protease-activated receptors: contribution to physiology and disease.
    Ossovskaya VS; Bunnett NW
    Physiol Rev; 2004 Apr; 84(2):579-621. PubMed ID: 15044683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.